Fabio Marra
#132,351
Most Influential Person Now
Researcher
Fabio Marra's AcademicInfluence.com Rankings
Fabio Marracomputer-science Degrees
Computer Science
#5880
World Rank
#6204
Historical Rank
Artificial Intelligence
#1969
World Rank
#2003
Historical Rank
Database
#3003
World Rank
#3131
Historical Rank
Download Badge
Computer Science
Fabio Marra's Degrees
- PhD Computer Science University of Milan
- Bachelors Computer Science University of Milan
Similar Degrees You Can Earn
Why Is Fabio Marra Influential?
(Suggest an Edit or Addition)Fabio Marra's Published Works
Number of citations in a given year to any of this author's works
Total number of citations to an author for the works they published in a given year. This highlights publication of the most important work(s) by the author
Published Works
- Liver stiffness measurement predicts severe portal hypertension in patients with HCV‐related cirrhosis (2007) (689)
- Roles for chemokines in liver disease. (2014) (585)
- Differential effect of oleic and palmitic acid on lipid accumulation and apoptosis in cultured hepatocytes (2009) (504)
- Lipotoxicity and the gut-liver axis in NASH pathogenesis. (2018) (462)
- Adipokines in liver diseases (2009) (461)
- Cytokine receptors and signaling in hepatic stellate cells. (2001) (449)
- Concomitant activation of the JAK/STAT, PI3K/AKT, and ERK signaling is involved in leptin-mediated promotion of invasion and migration of hepatocellular carcinoma cells. (2007) (441)
- Molecular basis and mechanisms of progression of non-alcoholic steatohepatitis. (2008) (416)
- Acute viral hepatitis increases liver stiffness values measured by transient elastography (2007) (408)
- NASH limits anti-tumour surveillance in immunotherapy-treated HCC (2021) (402)
- Ligands of peroxisome proliferator-activated receptor gamma modulate profibrogenic and proinflammatory actions in hepatic stellate cells. (2000) (399)
- Increased risk of cardiovascular disease in non-alcoholic fatty liver disease: causal effect or epiphenomenon? (2008) (389)
- Genome-wide meta-analyses identify three loci associated with primary biliary cirrhosis (2010) (372)
- Accuracy and reproducibility of transient elastography for the diagnosis of fibrosis in pediatric nonalcoholic steatohepatitis (2008) (358)
- Upregulation of proinflammatory and proangiogenic cytokines by leptin in human hepatic stellate cells (2005) (321)
- Chemokines in liver inflammation and fibrosis. (2002) (312)
- Increased expression of monocyte chemotactic protein-1 during active hepatic fibrogenesis: correlation with monocyte infiltration. (1998) (311)
- Reliability of transient elastography for the diagnosis of advanced fibrosis in chronic hepatitis C (2008) (291)
- HNE interacts directly with JNK isoforms in human hepatic stellate cells. (1998) (290)
- Practice guidelines for the diagnosis and management of nonalcoholic fatty liver disease. A decalogue from the Italian Association for the Study of the Liver (AISF) Expert Committee. (2010) (283)
- Signal Transduction by the Chemokine Receptor CXCR3 (2001) (276)
- Monocyte chemotactic protein‐1 as a chemoattractant for human hepatic stellate cells (1999) (267)
- AISF position paper on nonalcoholic fatty liver disease (NAFLD): Updates and future directions. (2017) (243)
- International genome-wide meta-analysis identifies new primary biliary cirrhosis risk loci and targetable pathogenic pathways (2015) (233)
- Signal transduction in hepatic stellate cells. (2008) (232)
- Cultured human liver fat-storing cells produce monocyte chemotactic protein-1. Regulation by proinflammatory cytokines. (1993) (217)
- Proangiogenic cytokines as hypoxia-dependent factors stimulating migration of human hepatic stellate cells. (2007) (204)
- Technology Insight: noninvasive assessment of liver fibrosis by biochemical scores and elastography (2008) (195)
- Hepatic stellate cells and the regulation of liver inflammation. (1999) (190)
- Silybin, a component of sylimarin, exerts anti-inflammatory and anti-fibrogenic effects on human hepatic stellate cells. (2009) (183)
- Liver stiffness is influenced by a standardized meal in patients with chronic hepatitis C virus at different stages of fibrotic evolution (2013) (176)
- Improved noninvasive prediction of liver fibrosis by liver stiffness measurement in patients with nonalcoholic fatty liver disease accounting for controlled attenuation parameter values (2017) (174)
- Molecular Pathogenesis of NASH (2016) (172)
- Monocyte chemotactic peptide-1 expression in acute and chronic human nephritides: a pathogenetic role in interstitial monocytes recruitment. (1996) (169)
- Myofibroblast - like cells and liver fibrogenesis: Emerging concepts in a rapidly moving scenario. (2008) (162)
- Extracellular signal‐regulated kinase activation differentially regulates platelet‐derived growth factor's actions in hepatic stellate cells, and is induced by In Vivo liver injury in the rat (1999) (160)
- The PNPLA3 I148M variant modulates the fibrogenic phenotype of human hepatic stellate cells (2017) (160)
- Extracellular signal-regulated kinases modulate capacitation of human spermatozoa. (1998) (156)
- Pathophysiology of NASH: perspectives for a targeted treatment. (2013) (152)
- Overexpression of Bcl-2 by activated human hepatic stellate cells: resistance to apoptosis as a mechanism of progressive hepatic fibrogenesis in humans (2005) (148)
- Resistin as an intrahepatic cytokine: overexpression during chronic injury and induction of proinflammatory actions in hepatic stellate cells. (2006) (146)
- The chemokine CCL21 modulates lymphocyte recruitment and fibrosis in chronic hepatitis C. (2003) (144)
- gp120 modulates the biology of human hepatic stellate cells: a link between HIV infection and liver fibrogenesis (2009) (138)
- Dendrosomal curcumin nanoformulation downregulates pluripotency genes via miR-145 activation in U87MG glioblastoma cells (2014) (129)
- Serial combination of non‐invasive tools improves the diagnostic accuracy of severe liver fibrosis in patients with NAFLD (2017) (128)
- 4-Hydroxynonenal as a selective pro-fibrogenic stimulus for activated human hepatic stellate cells. (2004) (121)
- Adenosine monophosphate–activated protein kinase modulates the activated phenotype of hepatic stellate cells (2007) (120)
- Thrombin stimulates proliferation of liver fat‐storing cells and expression of monocyte chemotactic protein‐1: Potential role in liver injury (1995) (117)
- The role of adipokines in liver fibrosis. (2008) (117)
- Expression of platelet-derived growth factor in newly formed cholangiocytes during experimental biliary fibrosis in rats. (1999) (117)
- Challenges of advanced hepatocellular carcinoma (2016) (113)
- Transcriptomic profiling across the nonalcoholic fatty liver disease spectrum reveals gene signatures for steatohepatitis and fibrosis (2020) (112)
- LMW-PTP is a negative regulator of insulin-mediated mitotic and metabolic signalling. (1997) (111)
- Evidence for a storage pool defect in platelets from cirrhotic patients with defective aggregation. (1992) (111)
- American Journal of Physiology: Gastrointestinal and Liver Physiology American Journal of Physiology: Heart and Circulatory Physi- QlQgY American Journal of Physiology: Regulatory, Integrative and Comparative Physiology American Journal of Physiology: Renal, Fluid and Electrolyte (2003) (108)
- Up-regulated expression of fractalkine and its receptor CX3CR1 during liver injury in humans. (2002) (108)
- Intracellular reactive oxygen species are required for directional migration of resident and bone marrow-derived hepatic pro-fibrogenic cells. (2011) (105)
- Nitrovasodilators inhibit platelet-derived growth factor-induced proliferation and migration of activated human hepatic stellate cells. (2000) (105)
- Increased phosphorylation of AKAP by inhibition of phosphatidylinositol 3-kinase enhances human sperm motility through tail recruitment of protein kinase A (2004) (102)
- Validity criteria for the diagnosis of fatty liver by M probe-based controlled attenuation parameter. (2017) (101)
- Expression of monocyte chemotactic protein-1 precedes monocyte recruitment in a rat model of acute liver injury, and is modulated by vitamin E. (1999) (99)
- MERTK rs4374383 polymorphism affects the severity of fibrosis in non-alcoholic fatty liver disease. (2016) (98)
- Efficacy and safety of the stepped care medical treatment of ascites in liver cirrhosis: a randomized controlled clinical trial comparing two diets with different sodium content. (2008) (98)
- Prevention of severe toxic liver injury and oxidative stress in MCP-1-deficient mice. (2007) (97)
- Non-invasive prediction of esophageal varices by stiffness and platelet in non-alcoholic fatty liver disease cirrhosis. (2018) (97)
- Expression of the thrombin receptor in human liver: Up‐regulation during acute and chronic injury (1998) (96)
- THERAPEUTIC AND ANTILIPOPEROXIDANT EFFECTS OF SILYBIN-PHOSPHATIDYLCHOLINE COMPLEX IN CHRONIC LIVER DISEASE: PRELIMINARY RESULTS (1993) (96)
- Leptin and liver fibrosis: a matter of fat. (2002) (93)
- Transforming growth factor‐β1 regulates platelet‐derived growth factor receptor β subunit in human liver fat‐storing cells (1995) (92)
- Curcumin limits the fibrogenic evolution of experimental steatohepatitis (2010) (90)
- Mononuclear cells in liver fibrosis (2009) (88)
- Involvement of phosphatidylinositol 3‐kinase in the activation of extracellular signal‐regulated kinase by PDGF in hepatic stellate cells (1995) (88)
- The Src and Signal Transducers and Activators of Transcription Pathways As Specific Targets for Low Molecular Weight Phosphotyrosine-protein Phosphatase in Platelet-derived Growth Factor Signaling* (1998) (84)
- Dose dependent and divergent effects of superoxide anion on cell death, proliferation, and migration of activated human hepatic stellate cells (2005) (84)
- Pretreatment prediction of response to ursodeoxycholic acid in primary biliary cholangitis: development and validation of the UDCA Response Score. (2018) (83)
- Patients with advanced hepatocellular carcinoma need a personalized management: A lesson from clinical practice (2018) (82)
- Hepatocellular carcinoma recurrence in patients with curative resection or ablation: impact of HCV eradication does not depend on the use of interferon (2017) (81)
- Oxidative stress parameters in paediatric non-alcoholic fatty liver disease. (2010) (81)
- Diagnostic accuracy of elastography and magnetic resonance imaging in patients with NAFLD: a systematic review and meta-analysis. (2021) (80)
- Plasma levels of brain natriuretic peptide in patients with cirrhosis (1992) (79)
- Effects of low-dose captopril on renal hemodynamics and function in patients with cirrhosis of the liver. (1993) (77)
- Hepatic decompensation is the major driver of death in HCV-infected cirrhotic patients with successfully treated early hepatocellular carcinoma. (2017) (77)
- Interferon-gamma-mediated activation of STAT1alpha regulates growth factor-induced mitogenesis. (1996) (76)
- Agonist‐specific regulation of monocyte chemoattractant protein‐1 expression by cyclooxygenase metabolites in hepatic stellate cells (2001) (74)
- Phosphatidylinositol-3 kinase and extracellular signal-regulated kinase mediate the chemotactic and mitogenic effects of insulin-like growth factor-I in human hepatic stellate cells. (2000) (73)
- The biphasic nature of hypoxia‐induced directional migration of activated human hepatic stellate cells (2012) (73)
- Arachidonic acid derivatives and renal function in liver cirrhosis. (1997) (73)
- Role of the stromal-derived factor-1 (SDF-1)-CXCR4 axis in the interaction between hepatic stellate cells and cholangiocarcinoma. (2012) (72)
- Under‐dilated TIPS Associate With Efficacy and Reduced Encephalopathy in a Prospective, Non‐randomized Study of Patients With Cirrhosis (2018) (72)
- Refining the Baveno VI elastography criteria for the definition of compensated advanced chronic liver disease. (2020) (71)
- The evolutionary scenario of hepatocellular carcinoma in Italy: an update (2017) (71)
- Fibrosis in alcoholic and nonalcoholic steatohepatitis. (2011) (71)
- c-Src activates both STAT1 and STAT3 in PDGF-stimulated NIH3T3 cells. (1997) (71)
- Diagnostic performance of FibroTest, SteatoTest and ActiTest in patients with NAFLD using the SAF score as histological reference (2016) (70)
- Defective signal transduction in platelets from cirrhotics is associated with increased cyclic nucleotides. (1993) (66)
- Renal hemodynamic and natriuretic effects of human atrial natriuretic factor infusion in cirrhosis with ascites. (1989) (65)
- Activation of p38(MAPK) mediates the angiostatic effect of the chemokine receptor CXCR3-B. (2008) (64)
- Induction of procollagen type I gene expression and synthesis in human hepatic stellate cells by 4-hydroxy-2,3-nonenal and other 4-hydroxy-2,3-alkenals is related to their molecular structure. (1996) (62)
- Regulation of platelet-derived growth factor secretion and gene expression in human liver fat-storing cells. (1994) (61)
- Interaction between 4-hydroxy-2,3-alkenals and the platelet-derived growth factor-beta receptor. Reduced tyrosine phosphorylation and downstream signaling in hepatic stellate cells. (2000) (61)
- Thiazolidinedione treatment inhibits bile duct proliferation and fibrosis in a rat model of chronic cholestasis. (2005) (60)
- Inhibition by pentoxifylline of extracellular signal‐regulated kinase activation by platelet‐derived growth factor in hepatic stellate cells (1996) (59)
- ERK5 differentially regulates PDGF-induced proliferation and migration of hepatic stellate cells. (2008) (59)
- Fibrogenic signalling in hepatic stellate cells. (2010) (59)
- The mitogen-activated protein kinase ERK5 regulates the development and growth of hepatocellular carcinoma (2014) (57)
- Lack of CC chemokine ligand 2 differentially affects inflammation and fibrosis according to the genetic background in a murine model of steatohepatitis (2012) (57)
- Phosphatidylinositol 3-kinase inhibition enhances human sperm motility. (2001) (55)
- Adipokines and redox signaling: impact on fatty liver disease. (2011) (54)
- Antifibrogenic effects of canrenone, an antialdosteronic drug, on human hepatic stellate cells. (2003) (52)
- The Role of Stroma in Cholangiocarcinoma: The Intriguing Interplay between Fibroblastic Component, Immune Cell Subsets and Tumor Epithelium (2018) (51)
- Molecular Mechanisms of Hepatic Fibrosis in Non-Alcoholic Steatohepatitis (2010) (51)
- Longitudinal assessment of liver stiffness in patients undergoing antiviral treatment for hepatitis C. (2013) (51)
- Sex steroids and odorants modulate gonadotropin-releasing hormone secretion in primary cultures of human olfactory cells. (1999) (49)
- Mammalian target of rapamycin mediates the angiogenic effects of leptin in human hepatic stellate cells. (2011) (43)
- ADMA correlates with portal pressure in patients with compensated cirrhosis (2007) (41)
- Differential requirement of members of the MAPK family for CCL2 expression by hepatic stellate cells. (2004) (41)
- Adipokines and liver fibrosis. (2005) (41)
- Impaired superoxide anion, platelet-activating factor, and leukotriene B4 synthesis by neutrophils in cirrhosis. (1993) (40)
- Non-invasive assessment of fibrosis in non-alcoholic fatty liver disease (NAFLD) (2009) (40)
- Nonalcoholic fatty liver in nondiabetic patients with acute coronary syndromes (2013) (40)
- Safety and efficacy of ruxolitinib in splanchnic vein thrombosis associated with myeloproliferative neoplasms (2017) (40)
- Biosynthesis of platelet-activating factor and its 1O-acyl analogue by liver fat-storing cells. (1994) (39)
- Mitochondrial oxidative metabolism contributes to a cancer stem cell phenotype in cholangiocarcinoma. (2021) (39)
- Liver stiffness correlates with methotrexate cumulative dose in patients with rheumatoid arthritis. (2012) (39)
- Leptin and liver tissue repair: do rodent models provide the answers? (2007) (38)
- Comparison of the effects of torasemide and furosemide in nonazotemic cirrhotic patients with ascites: A randomized, double‐blind study (1991) (38)
- The metabolic syndrome and chronic liver disease. (2014) (38)
- PDGF stimulates tyrosine phosphorylation of JAK 1 protein tyrosine kinase in human mesangial cells. (1996) (37)
- Cellular and Molecular Mechanisms Underlying Liver Fibrosis Regression (2021) (36)
- Transjugular intrahepatic portosystemic shunt (TIPS): current indications and strategies to improve the outcomes (2020) (36)
- Transforming growth factor-beta 1 regulates platelet-derived growth factor receptor beta subunit in human liver fat-storing cells. (1995) (36)
- The inflammasome in liver disease. (2016) (36)
- Role of hepatic stellate cells in the pathogenesis of portal hypertension. (2002) (36)
- Epidermal growth factor, epidermal growth factor receptor, and transforming growth factor-alpha in human hyperplastic prostate tissue: expression and cellular localization. (1996) (36)
- Glycogenic hepatopathy associated with type 1 diabetes mellitus as a cause of recurrent liver damage. (2012) (35)
- Performance of Doppler ultrasound in the prediction of severe portal hypertension in hepatitis C virus‐related chronic liver disease (2007) (33)
- Role of adipocytokines in hepatic fibrosis. (2010) (33)
- Defective aggregation in cirrhosis is independent of in vivo platelet activation. (1996) (33)
- Elastography for the non-invasive assessment of liver disease: limitations and future developments (2009) (33)
- Metronomic capecitabine as second-line treatment for hepatocellular carcinoma after sorafenib discontinuation (2018) (31)
- Radiological Patterns of Lung Involvement in Inflammatory Bowel Disease (2018) (31)
- NLRP3 inflammasome as a target of berberine in experimental murine liver injury: interference with P2X7 signalling. (2016) (31)
- Hepatic stellate cell nomenclature. (1996) (30)
- Utility of Tumor Burden Score to Stratify Prognosis of Patients with Hepatocellular Cancer: Results of 4759 Cases from ITA.LI.CA Study Group (2018) (30)
- Renaming cytokines: MCP-1, Major Chemokine in Pancreatitis (2005) (29)
- Ang II Upregulation of the T-lymphocyte renin-angiotensin system is amplified by low-grade inflammation in human hypertension. (2011) (29)
- Nuclear factor-κB inhibition and non-alcoholic steatohepatitis: inflammation as a target for therapy (2008) (29)
- Myostatin regulates the fibrogenic phenotype of hepatic stellate cells via c-jun N-terminal kinase activation. (2019) (28)
- Integrin‐mediated stimulation of monocyte chemotactic protein‐1 expression (1997) (28)
- MARCKS is a downstream effector in platelet-derived growth factor-induced cell motility in activated human hepatic stellate cells. (2008) (28)
- Predictors of survival in patients with established cirrhosis and hepatocellular carcinoma treated with sorafenib. (2014) (27)
- Modulation of Liver Fibrosis by Adipokines (2011) (27)
- Management strategies for hepatocellular carcinoma: old certainties and new realities (2016) (26)
- Nuclear localization of TRK-A in liver cells. (2008) (26)
- Non-invasive assessment of fibrosis in non-alcoholic fatty liver disease. (2009) (26)
- Clinical impact of sexual dimorphism in non‐alcoholic fatty liver disease (NAFLD) and non‐alcoholic steatohepatitis (NASH) (2021) (25)
- PNPLA3 I148M Variant Impairs Liver X Receptor Signaling and Cholesterol Homeostasis in Human Hepatic Stellate Cells (2019) (25)
- Evaluation of intracellular signalling pathways in response to insulin-like growth factor I in apoptotic-resistant activated human hepatic stellate cells (2009) (25)
- The protein kinase CK2 contributes to the malignant phenotype of cholangiocarcinoma cells (2019) (24)
- Pharmacokinetics and pharmacodynamics of torasemide and furosemide in patients with diuretic resistant ascites. (1996) (23)
- Thrombopoietin stimulates migration and activates multiple signaling pathways in hepatoblastoma cells. (2006) (23)
- Angiotensin II upregulates renin–angiotensin system in human isolated T lymphocytes (2008) (23)
- HIV‐1 gp120 signaling through TLR4 modulates innate immune activation in human macrophages and the biology of hepatic stellate cells (2016) (23)
- Restaging Patients With Hepatocellular Carcinoma Before Additional Treatment Decisions: A Multicenter Cohort Study (2018) (23)
- Non‐invasive assessment of liver fibrosis in patients with HBV‐related chronic liver disease undergoing antiviral treatment: A preliminary study (2017) (23)
- Measurement of Gamma Glutamyl Transferase to Determine Risk of Liver Transplantation or Death in Patients With Primary Biliary Cholangitis. (2020) (22)
- Thrombin stimulates association of src homology domain containing adaptor protein Nck with pp125FAK. (1996) (22)
- Review article: the pathogenesis of fibrosis in non‐alcoholic steatohepatitis (2005) (21)
- Effects of dietary supplementation with arachidonic acid on platelet and renal function in patients with cirrhosis. (2004) (21)
- Real-Life Clinical Data of Cabozantinib for Unresectable Hepatocellular Carcinoma (2021) (20)
- Real-Life Clinical Data of Lenvatinib versus Sorafenib for Unresectable Hepatocellular Carcinoma in Italy (2021) (20)
- [Non-alcoholic fatty liver disease: a new challenge for cardiologists]. (2010) (19)
- Thiazolidinediones and hepatic fibrosis: don’t wait too long (2006) (18)
- Therapeutic application of stem cells in gastroenterology: an up-date. (2011) (17)
- n‐3 polyunsaturated fatty acids worsen inflammation and fibrosis in experimental nonalcoholic steatohepatitis (2014) (17)
- Alcohol associated liver disease 2020: A clinical practice guideline by the Italian Association for the Study of the Liver (AISF). (2020) (17)
- Nonalcoholic steatohepatitis in hepatocarcinoma: new insights about its prognostic role in patients treated with lenvatinib (2021) (17)
- Soluble CD163 and mannose receptor as markers of liver disease severity and prognosis in patients with primary biliary cholangitis (2020) (16)
- AQP3 is regulated by PPARγ and JNK in hepatic stellate cells carrying PNPLA3 I148M (2017) (16)
- X chromosome contribution to the genetic architecture of primary biliary cholangitis. (2021) (16)
- Thromboxane-receptor blockade increases water diuresis in cirrhotic patients with ascites. (1992) (16)
- Antitumor Activity of a Novel Fibroblast Growth Factor Receptor (FGFR) Inhibitor for Intrahepatic Cholangiocarcinoma. (2019) (16)
- Overview of Prognostic Systems for Hepatocellular Carcinoma and ITA.LI.CA External Validation of MESH and CNLC Classifications (2021) (15)
- Evaluation of the prognostic value of liver stiffness in patients with hepatitis C virus treated with triple or dual antiviral therapy: A prospective pilot study. (2015) (15)
- PCSK9 rs11591147 R46L loss‐of‐function variant protects against liver damage in individuals with NAFLD (2020) (15)
- Thrombocytopenia in chronic liver disease: lessons from transplanted patients. (2007) (15)
- Impact of psychosocial status on liver transplant process. (2019) (14)
- Effects of repeated atrial natriuretic peptide bolus injections in cirrhotic patients with refractory ascites. (2008) (14)
- Role of Myeloid-Epithelial-Reproductive Tyrosine Kinase and Macrophage Polarization in the Progression of Atherosclerotic Lesions Associated With Nonalcoholic Fatty Liver Disease (2019) (14)
- Liver fibrosis in the context of nonalcoholic steatohepatitis: the role of adipokines. (2018) (14)
- Targeting a phospho-STAT3-miRNAs pathway improves vesicular hepatic steatosis in an in vitro and in vivo model (2018) (13)
- NASH: are genes blowing the hits? (2004) (13)
- Multifaceted Aspects of Metabolic Plasticity in Human Cholangiocarcinoma: An Overview of Current Perspectives (2020) (13)
- Effects of supplementation with unsaturated fatty acids on plasma and membrane lipid composition and platelet function in patients with cirrhosis and defective aggregation. (1998) (13)
- Acute on chronic liver failure: From pathophysiology to clinical management (2013) (12)
- Nonalcoholic steatohepatitis before and after liver transplant: keeping up with the times (2018) (12)
- Guanosine 3′: 5′‐cyclic monophosphate‐dependent pathway alterations in ventricular cardiomyocytes of spontaneously hypertensive rats (2001) (12)
- CXCR7 contributes to the aggressive phenotype of cholangiocarcinoma cells. (2019) (12)
- Hepatic Notch1 deletion predisposes to diabetes and steatosis via glucose-6-phosphatase and perilipin-5 upregulation (2016) (12)
- Metabolic Reprogramming in Cholangiocarcinoma. (2022) (12)
- Lack of nitric oxide‐ and guanosine 3′:5′‐cyclic monophosphate‐dependent regulation of α‐thrombin‐induced calcium transient in endothelial cells of spontaneously hypertensive rat hearts (2000) (11)
- Identification of lenvatinib prognostic index via recursive partitioning analysis in advanced hepatocellular carcinoma (2021) (10)
- Effects of rhein on renal arachidonic acid metabolism and renal function in patients with congestive heart failure (2004) (10)
- Pre-transplant diabetes predicts atherosclerotic vascular events and cardiovascular mortality in liver transplant recipients: a long-term follow-up study. (2020) (10)
- gp120 induces directional migration of human hepatic stellate cells: A link between HIV infection and liver fibrogenesis (2008) (10)
- Increased serum miR-193a-5p during non-alcoholic fatty liver disease progression: Diagnostic and mechanistic relevance (2021) (9)
- Cytokine Production and Signaling in Stellate Cells (2015) (9)
- Assessment of liver fibrosis in primary biliary cholangitis: Comparison between indirect serum markers and fibrosis morphometry. (2016) (9)
- Treatment of Hepatocellular Carcinoma with Immune Checkpoint Inhibitors and Applicability of First-Line Atezolizumab/Bevacizumab in a Real-Life Setting (2021) (9)
- Role of Chemokines in the Biology of Cholangiocarcinoma (2020) (9)
- Constitutive activation of the MAPK pathway mediates v-fes-induced mitogenesis in murine macrophages. (2000) (9)
- Extracellular Signal‐Regulated Kinase 5 Regulates the Malignant Phenotype of Cholangiocarcinoma Cells (2021) (9)
- Monofocal hepatocellular carcinoma: How much does size matter? (2020) (9)
- Coagulation defects in cirrhosis--old dogmas not yet ready for burial. (2006) (8)
- Comparison of prognostic models in advanced hepatocellular carcinoma patients undergoing Sorafenib: A multicenter study. (2020) (8)
- Transient Hepatic Parenchymal Enhancement detected at dynamic imaging: a short instruction manual for the clinician. (2012) (8)
- Screening of distress among hospitalized patients in a department of internal medicine. (2015) (8)
- Metabolic disorders across hepatocellular carcinoma in Italy (2018) (8)
- Stemness features in liver cancer (2018) (7)
- Pattern of macrovascular invasion in hepatocellular carcinoma (2021) (7)
- Novel Aspects in the Pathogenesis of Nonalcoholic Steatohepatitis. (2016) (7)
- A Nomogram-Based Prognostic Model for Advanced Hepatocellular Carcinoma Patients Treated with Sorafenib: A Multicenter Study (2021) (7)
- Surveillance as Determinant of Long-Term Survival in Non-Transplanted Hepatocellular Carcinoma Patients (2021) (7)
- Selective inhibition of NF-κB in Kupffer cells: good, but not for everything (2009) (7)
- Invasion and Migration of Hepatocellular Carcinoma Cells ERK Signaling Is Involved in Leptin-Mediated Promotion of Concomitant Activation of the JAK/STAT, PI3K/AKT, and Updated Version (2007) (6)
- Time-Varying mHAP-III Is the Most Accurate Predictor of Survival in Patients with Hepatocellular Carcinoma Undergoing Transarterial Chemoembolization (2021) (6)
- Complications of cirrhosis: is endothelium guilty? (1999) (6)
- Changes in hepatocellular carcinoma aggressiveness characteristics with an increase in tumor diameter (2021) (6)
- Uncontrolled donation after circulatory death and liver transplantation: evidence and unresolved issues. (2020) (6)
- Evidence for alpha 1-adrenoreceptor hyperresponsiveness in hypotensive cirrhotic patients with ascites. (1991) (6)
- Sudden cardiac death in a patient with advanced hepatocellular carcinoma with good response to sorafenib treatment: A case report with literature analysis. (2017) (5)
- Reply to 'Genetic and clinical data reinforce the role of GAS6 and TAM receptors in liver fibrosis'. (2016) (5)
- Monocyte chemotactic protein-1 stimulates hepatic stellate cell chemotaxis (1998) (5)
- Torasemide in the treatment of patients with cirrhosis and ascites (2004) (5)
- Liver Fibrosis and Leptin (2016) (5)
- Nuclear localization of the nerve growth factor (NGF) receptor, TRK-A in liver cells (2003) (5)
- Silybin is a direct antifibrogenic and antiinflammatory agent: Cellular and molecular mechanisms (2008) (5)
- Oxidative Stress and Liver Fibrogenesis (2015) (5)
- Oncostatin M is overexpressed in NASH‐related hepatocellular carcinoma and promotes cancer cell invasiveness and angiogenesis (2022) (5)
- The Role of the Hedgehog Pathway in Cholangiocarcinoma (2021) (4)
- Long Term Follow up of a Phase 2 Study of Ruxolitinib in Patients with Splanchnic Vein Thrombosis Associated with Myeloproliferative Neoplasm (2015) (4)
- The pathogenesis of fibrosis in non-alcoholic steatohepatitis (2005) (4)
- Macrophage MerTK promotes profibrogenic cross-talk with hepatic stellate cells via soluble mediators (2022) (4)
- 1280 Leptin receptors on human hepatic stellate cells mediate the expression of pro-inflammatory and pro-angiogenic cytokines (2003) (4)
- Pathogenetic factors of renal dysfunction in chronic liver disease (1989) (4)
- Cells in the Liver—Functions in Health and Disease (2011) (4)
- Paradoxical embolization in TIPS: take a closer look to the heart. (2015) (4)
- Non-alcoholic fatty liver disease in adults 2021: A clinical practice guideline of the Italian Association for the Study of the Liver (AISF), the Italian Society of Diabetology (SID) and the Italian Society of Obesity (SIO). (2021) (4)
- Elevated plasma levels of urotensin II do not correlate with systemic haemodynamics in patients with cirrhosis. (2011) (4)
- Marra F, DeFranco R & Grappone C et al. Increased expression of monocyte chemotactic protein-1 during active hepatic fibrogenesis: Correlation with monocyte infiltration. Am J Pathol152: 423-430 (1998) (4)
- Super-Resolution Microscopy Reveals an Altered Fibrin Network in Cirrhosis: The Key Role of Oxidative Stress in Fibrinogen Structural Modifications (2020) (4)
- Non-alcoholic fatty liver disease in adults 2021: A clinical practice guideline of the Italian Association for the Study of the Liver (AISF), the Italian Society of Diabetology (SID) and the Italian Society of Obesity (SIO). (2021) (4)
- CT volume of enhancement of disease (VED) can predict the early response to treatment and overall survival in patients with advanced HCC treated with sorafenib (2020) (3)
- From advanced disease to transplantation: an overview of the liver at the time of COVID-19 pandemic (2021) (3)
- IGF-I is a survival factor for human hepatic stellate cells (HSC): involvement of PI 3-K and C-Akt (2001) (3)
- Recalibrating survival prediction among patients receiving trans‐arterial chemoembolization for hepatocellular carcinoma (2021) (3)
- Aggressive Gastric Carcinoma Producing Alpha-Fetoprotein: A Case Report and Review of the Literature (2014) (3)
- [Thiazolidinediones and PPARgamma system in repair of liver damage]. (2002) (3)
- Cross-talk between phosphatidylinositol 3-kinase (PI3-K) and the NA+/H+ exchanger in hepatic stellate cells (HSC): effect of canrenone (2001) (3)
- Immunomodulation: a new approach to the therapy of cirrhosis? (2010) (3)
- A Phase 2 Study Of Ruxolitinib In Patients With Splanchnic Vein Thrombosis Associated With Myeloproliferative Neoplasm. Preliminary Results (2013) (3)
- Metabolic Disorders After Liver Transplantation. (2020) (3)
- P0340 : Clinical patterns of hepatocellular carcinoma (HCC) in non alcoholic fatty liver disease (NAFLD): A multicenter case-control study (2015) (3)
- Activated human hepatic stellate cells are resistant to classic pro-apoptotic stimuli (2003) (3)
- Predictors of solid extra-hepatic non-skin cancer in liver transplant recipients and analysis of survival: a long-term follow-up study. (2022) (2)
- 17 Expression of adiponectin receptors by human hepatic stellate cells (HSC) modulates the profibrogenic actions of platelet-derived growth factor (PDGF) (2004) (2)
- Liver stiffness measurement (LSM) is able to predict severe portal hypertension in patients with HCV-related advanced chronic liver disease (2007) (2)
- DNA Damage Response Inhibitors in Cholangiocarcinoma: Current Progress and Perspectives (2022) (2)
- Clinical patterns of hepatocellular carcinoma (HCC) in non alcoholic fatty liver disease (NAFLD): a multicenter case-control study (2015) (2)
- HIV-1 gp 120 signaling through TLR 4 modulates innate immune activation in human macrophages and the biology of hepatic stellate cells (2016) (2)
- A Phase 2 Study of Ruxolitinib in Patients with Splanchnic Vein Thrombosis Associated with Myeloproliferative Neoplasm: A Study from the AGIMM Group (2014) (2)
- Alcohol use disorder and liver transplant: new perspectives and critical issues (2020) (2)
- Serial combination of noninvasive tools improves the diagnostic accuracy of severe liver fibrosis in patients with nonalcoholic fatty liver disease (2017) (2)
- Modulation of the NLRP3 inflammasome pathway mediates the anti-inflammatory action of indoleamine dioxygenase in experimental NASH (2018) (2)
- 321 High levels of BCL-2, C-AKT and TRK-A in activated human hepatic stellate cells: Possible mechanisms for survival to apoptosis induction (2004) (2)
- Pre-treatment risk stratification in primary biliary cholangitis: 51st Annual Meeting of the Italian Association for the Study of the Liver – A.I.S.F. (2018) (2)
- Surveillance for hepatocellular carcinoma with a 3-months interval in "extremely high-risk" patients does not further improve survival. (2021) (2)
- Lenvatinib: established and promising drug for the treatment of advanced hepatocellular carcinoma (2021) (2)
- Validation of the Baveno VI elastography criteria for the definition of compensated advanced chronic liver disease: an individual patient meta-analysis (2017) (2)
- Role of the protein kinase CK2 in the biology of cholangiocarcinoma cells (2016) (2)
- Nuclear localization of TRKA in liver cells (2007) (1)
- 3. Stellate cells (2015) (1)
- Renal effects of a thromboxane (TX) A2 receptor antagonist (ONO-3708) in cirrhotics with ascites(C) (1990) (1)
- A Large Rheumatoid Nodule Mimicking Hepatic Malignancy (2019) (1)
- Role of the protein tyrosine kinase Mer (MerTK) in the cross-talk between macrophages and hepatic stellate cells (2018) (1)
- Faculty Opinions recommendation of Adiponectin modulates C-jun N-terminal kinase and mammalian target of rapamycin and inhibits hepatocellular carcinoma. (2010) (1)
- CXCR3-binding chemokines as survival factors in human hepatic stellate cells (2001) (1)
- Time-varying mHAP III is the most accurate score in predicting survival in patients with hepatocellular carcinoma (HCC) undergoing trans-arterial chemoembolization (TACE) (2019) (1)
- 30 THE CHEMOKINE RECEPTOR CCR5 MEDIATES THE PROFIBROGENIC ACTIONS OF THE HIV ENVELOPE PROTEIN GP120 IN HUMAN HEPATIC STELLATE CELLS (2009) (1)
- Oncostatin M: From Intracellular Signaling to Therapeutic Targets in Liver Cancer (2022) (1)
- The ALBI and p-ALBI grades predict survival in patients with hepatocellular carcinoma undergoing transarterial chemoembolization (TACE) (2018) (1)
- Hepatic brucellar abscess. (2013) (1)
- Transjugular Intrahepatic Portosystemic Shunt does not affect the efficacy and safety of direct-acting antivirals in patients with advanced cirrhosis: A real-life, case-control study. (2019) (1)
- T-26 The myostatin system is expressed in the liver and its activation mediates profibrogenic actions via c-Jun N-terminal kinase (2013) (1)
- Resistin as an Intrahepatic Cytokine (2010) (1)
- Ghrelin and fibrogenesis: relief for a hungry liver. (2011) (1)
- Migration of human activated hepatic stellate cells induced by superoxide anion: a Ras/Erk – dependent event that does not affect proliferation (2005) (1)
- 1036 THE ADIPOKINE CHEMERIN AS A NOVEL FACTOR REGULATING THE FIBROGENIC PHENOTYPE OF HUMAN HEPATIC STELLATE CELLS (2011) (1)
- REVIEWS IN BASIC AND CLINICAL GASTROENTEROLOGY AND HEPATOLOGY (2014) (1)
- 484 INTRACELLULAR REDOX CHANGES AND C-JUN N-TERMINAL KINASE ACTIVATION AS CRUCIAL EVENTS IN CYTOKINE-INDUCED CHEMOTAXIS OF HUMAN ACTIVATED HEPATIC STELLATE CELLS (2008) (1)
- Cytokine – induced migration of human hepatic stellate cells requires activation of c-jun n-terminal kinase and intracellular generation of reactive oxygen species (2007) (1)
- Oncostatin M induces increased invasiveness and angiogenesis in hepatic cancer cells through HIF1α-related release of VEGF-A (2017) (1)
- A NOVEL ROLE FOR THE KYNURENINE PATHWAY IN EXPERIMENTAL STEATOHEPATITIS (2015) (1)
- OC-26 The emerging impact of HCC-NAFLD in Italy (2012) (1)
- 4-hydroxy-2,3-alkenals impair tyrosine phosphorylation and downstream signaling of the PDGF-β receptor in human hepatic stellate cells (2000) (1)
- 285 HYPOXIA – INDUCED MIGRATION OF HEPATIC STELLATE CELLS AND BONE MARROW – DERIVED MESENCHYMAL STEM CELLS INVOLVES COMMON REDOX MECHANISMS (2009) (1)
- Epidermal growth factor (EGF) increases latent TGF-$beta; containing the 190 kDa binding protein in human liver fat-storing cells (1993) (1)
- Mechanisms of Fibrosis in Steatohepatitis (2014) (1)
- Angiogenesis inhibitors for advanced hepatocellular carcinoma: in search for the right partner (2020) (1)
- Profibrogenic Actions of Hepatic Stellate Cells: Major Intracellular Signaling Pathways (2003) (1)
- [Viral liver cirrhosis: natural course, pathogenesis and clinical implications of the complications]. (1996) (1)
- Upregulated expression of human thrombin receptor in acute and chronic liver disease (1995) (1)
- 762 TRANSIENT ELASTOGRAPHY (TE) IS MORE EFFECTIVE FOR THE IDENTIFICATION OF HCV PATIENTS WITH ADVANCED (F3-F4) RATHER THAN SIGNIFICANT (F2-F4) LIVER FIBROSIS (2008) (1)
- Noninvasive prediction of esophageal varices by liver stiffness measurement and platelet values in patients with liver cirrhosis due to nonalcoholic fatty liver disease: A multicenter cross-sectional study (2018) (0)
- Impaired cytosolic metabolism in platelets (PLT) from cirrhotics with defective aggregation (1990) (0)
- T.N.41 INTRACELLULAR GENERATION OF REACTIVE OXYGEN SPECIES AS A CRUCIAL REQUIREMENT FOR DIRECTIONAL MIGRATION OF HEPATIC PRO-FIBROGENIC CELLS (2010) (0)
- Hypoxia - and VEGF – dependent migration and chemotaxis of activated hepatic stellate cells operates through Flk-1 (2006) (0)
- Corrigendum to ‘An international genome-wide meta-analysis of primary biliary cholangitis: Novel risk loci and candidate drugs’ [J Hepatol 2021;75(3):572–581] (2021) (0)
- P609 PRO-INFLAMMATORY AND PRO-FIBROGENIC ACTIONS OF THE HIV-ENVELOPE PROTEIN GP120 ARE MEDIATED BY INFLAMMASOME ACTIVATION AND miR-29b (2014) (0)
- Chemokines modulate their own expression and matrix metalloproteinase secretion in human hepatic stellate cells (2001) (0)
- [78] COMPARISON BETWEEN HEPATIC VENOUS PRESSURE GRADIENT (HVPG) AND LIVER STIFFNESS MEASUREMENT (LSM) IN PATIENTS WITH HCV-RELATED FIBROSIS/CIRRHOSIS (2007) (0)
- The Cellular and Molecular Basis of Liver Fibrogenesis (1996) (0)
- F-31 Berberine ameliorates necroinflammation in experimental steatohepatitis, but is associated with extrahepatic toxicity (2012) (0)
- [99] EXPRESSION OF ANGIOGENIC CYTOKINES BY LEPTIN REQUIRES A TSC/M-TOR PATHWAY AND GENERATION OF REACTIVE OXYGEN SPECIES (ROS) IN HUMAN HEPATIC STELLATE CELLS (2007) (0)
- Involvement of the IDO-1 pathway in experimental NASH (2015) (0)
- THU-488-Acquisition of stem-like features in cholangiocarcinoma is associated with an oxidative metabolism (2019) (0)
- 288 A NEW FUNCTIONAL ROLE FOR NUCLEAR MARCKS DURING CELL CYCLE IN HUMAN HEPATIC STELLATE CELLS (2009) (0)
- SALLuting a new biomarker in hepatocellular carcinoma. (2014) (0)
- Acquisition of stem-like features in human cholangiocarcinoma is associated with an oxidative metabolism (2019) (0)
- 1107 THE INFLAMMASOME COMPLEX IS A TARGET OF THE HIV ENVELOPE PROTEIN gp120 IN HUMAN HEPATIC STELLATE CELLS (HSC) AND MONONUCLEAR CELLS (MC) (2013) (0)
- AMP-activated protein kinase (AMPK) blocks the effects of PDGF by PI3K-independent signals and is downregulated during in vivo activation of hepatic stellate cells (2007) (0)
- 20 Differential regulation of MCP-1 expression in hepatic stellate cells by members of the mitogen-activated protein kinase (MAPK) family (2003) (0)
- 868 STROMAL-DERIVED FACTOR-1 (SDF-1) – CXCR4 AXIS HAS AN IMPORTANT ROLE ON THE INTERACTION OF HUMAN HEPATIC STELLATE CELLS (HHSC) AND CC CELL LINES (2010) (0)
- Defective LTB4 prduction by whole blood and isolated polymorphonuclear cells in cirrhotics (C) (1990) (0)
- PS-095-MerTK-mediated cytokine secretion mediates a cross-talk between M2c macrophages and hepatic stellate cells to induce fibrosis (2019) (0)
- Differential inflammatory phenotypes upon genetic or pharmacologic inactivation of indoleamine dioxygenase in experimental steatohepatitis (2016) (0)
- Ganglioside patterns in the human cholangiocarcinoma stem cell subset (2020) (0)
- [713] CURCUMIN INHIBITS THE FIBROGENIC PROGRESSION OF MURINE STEATOHEPATITIS (2007) (0)
- 1237 THE GENETIC BACKGROUND DIFFERENTIALLY AFFECTS HEPATIC NECRO-INFLAMMATION IN RESPONSE TO CCL2 IN A MURINE MODEL OF STEATOHEPATITIS (2012) (0)
- c-ABL activity is required for the fibrogenetic behaviour of hepatic stellate cells (2008) (0)
- Acquisition of stem-like features in human cholangiocarcinoma is associated with an oxidative glucose metabolism (2018) (0)
- P428 5-METHYL-1-PHENYL-2-(1H)-PYRIDONE TREATMENT IMPROVES MARKERS OF HEPATIC FUNCTION AND FIBROSIS IN STEATOSIS INDUCED BY HIGH FAT/CARBOHYDRATE DIET (2014) (0)
- Differential regulation of monocyte chemoattractant protein-1 (MCP-1) expression in hepatic stellate cells by members of the mitogen-activated protein kinase (MAPK) family (2003) (0)
- Role of the receptor tyrosine kinase MER in the development of fibrosis in NAFLD (2015) (0)
- 1034 ONCOSTATIN M STIMULATES DIRECTIONAL MIGRATION OF HUMAN HEPATIC PROFIBROGENIC CELLS (2011) (0)
- Defective release and reduced total content of α and δ platelet (plt) granules in cirrhotic patients (C) is associated with in vivo platelet activation (1990) (0)
- Pre-treatment risk stratification in primary biliary cholangitis: a predictive model to guide first-line combination therapy (2018) (0)
- Regulation of PDGF A- and B-chain gene expression in cultured human fat-storing cells (1993) (0)
- Factors influencing patients' response to medical treatment of ascites: A randomized clinical trial (1991) (0)
- OC-5 Cytoskeletal rearrangement by the mitogen-activated protein kinase ERK5 interferes with the motile and invasive phenotype of hepatocellular carcinoma cells (2011) (0)
- 106 A role of resistin as a mediator of hepatic inflammation and oxidative stress (2006) (0)
- High-throughput RNA sequencing unravels pathways associated with the progression of non-alcoholic liver disease (2017) (0)
- PCSK9 rs11591147 R46L Loss-of-Function Variant Protects Against Liver Damage in Individuals with NAFLD (2020) (0)
- F-51 Berberine ameliorates hepatic injury in mice acting on the NALP3 inflammasome pathway (2013) (0)
- QT Adaptation during Exercise in Cirrhosis (2018) (0)
- FRI-321-Hepatocyte expression of the protein kinase ERK5 regulates insulin sensitivity (2019) (0)
- PCSK9 rs11591147 R46L loss-of-function variant protects against liver damage in individuals with non-alcoholic fatty liver (2020) (0)
- FRI-336-Lack of CCL2 limits the development of HCC in a model of obesity-associated carcinogenesis (2019) (0)
- Oncostatin M induces increased invasiveness and angiogenesis in hepatic cancer cells through HIF1alpha-related release of VEGF-A (2017) (0)
- Extracellular signal-regulated kinase 5 (ERK5) regulates growth, migration and invasion of cholangiocarcinoma (CCA) cells (2018) (0)
- 95 MONOCYTE CHEMOATTRACTANT PROTEIN-1 (MCP-1) IS REQUIRED FOR THE DEVELOPMENT OF INFLAMMATION, OXIDATIVE DAMAGE AND FIBROSIS IN MURINE STEATOHEPATITIS (2008) (0)
- The proto-oncogene tyrosine-protein kinase MER as a novel modulator of fibrogenesis in NAFLD (2015) (0)
- Cellular and molecular basis of fibrogenesis in NASH (2010) (0)
- Pre-transplant diabetes independently predicts atherosclerotic vascular event and death due to cardiovascular disease in liver transplant recipients: a long term multicenter observational study (2020) (0)
- Hepatocyte-specific deletion of ERK5 worsens insulin resistance in a murine model of nonalcoholic fatty liver disease (NAFLD) (2020) (0)
- 296 PDGFβ AND TGFβ1 STIMULATES HEPATIC STELLATE CELLS THROUGH C-ABL ACTIVATION (2009) (0)
- 96 NOTCH1 DELETION IN HEPATOCYTES PREDISPOSES TO DIABETES AND LIVER STEATOSIS THROUGH DYSREGULATION OF GENES INVOLVED IN GLUCOSE AND LIPID HOMEOSTASIS (2012) (0)
- Inhibition of indoleamine 2,3-dioxygenase ameliorates inflammation and fibrosis in experimental steatohepatitis (2014) (0)
- Faculty Opinions recommendation of Activator Protein 1 transcription factor Fos-related antigen 1 (Fra-1) is dispensable for murine liver fibrosis, but modulates xenobiotic metabolism. (2013) (0)
- Faculty Opinions recommendation of Mesenchymal stem cells promote chemoresistance by activating autophagy in intrahepatic cholangiocarcinoma. (2021) (0)
- 786: The mitogen-activated protein kinase ERK5 regulates the development and growth of hepatocellular carcinoma (2014) (0)
- Statin-induced, immune-mediated injury with simultaneous targeting of skeletal muscle, skin and liver (2021) (0)
- Mitochondrial oxidative metabolism contributes to maintain a cancer stem cell phenotype in cholangiocarcinoma (2020) (0)
- 4-Hydroxynonenal elicits in human hepatic stellate cells a c-jun/JNK2/AP-1 signalling pathway preceeded by early generation of nuclear adducts. (1997) (0)
- 16 Identification of a cross talk between the PDGF-beta receptor signalling pathway and the myristoylated alanine-rich PKC substrate (MARCKS) protein in activated human hepatic stellate cells (2004) (0)
- Faculty Opinions recommendation of CCR2 promotes hepatic fibrosis in mice. (2009) (0)
- 924 Protection from T cell-mediated hepatitis in CXCR3-deficient mice (2003) (0)
- The protease-inhibitor SerpinB3 outlines a stem-like subset in human cholangiocarcinoma (2018) (0)
- CS.01.3 THE EMERGING IMPACT OF HCC-NAFLD IN ITALY (2012) (0)
- Expression of IP-10 and its receptor CXCR3 in hepatic stellate cells identifies a novel autocrine and paracrine system (2000) (0)
- P.08.17 SAFETY AND TOLERABILITY OF SORAFENIB TREATMENT FOR HEPATOCELLULAR CARCINOMA IN PATIENTS WITH SEVERE IMPAIRMENT OF LIVER FUNCTION: A PROSPECTIVE STUDY (2012) (0)
- F.N.24 ERK5 IS OVEREXPRESSED IN HEPATOCELLULAR CARCINOMA (HCC), AND IS MODULATED BY SOLUBLE FACTORS IN HCC CELLS (2010) (0)
- Faculty Opinions recommendation of A Circular RNA, Cholangiocarcinoma-Associated Circular RNA 1, Contributes to Cholangiocarcinoma Progression, Induces Angiogenesis, and Disrupts Vascular Endothelial Barriers. (2021) (0)
- Expression of the chemokine CCL21 during chronic hepatitis C: potential role in inflammation and fibrosis (2002) (0)
- 892 ERK5 IS OVEREXPRESSED IN EXPERIMENTAL LIVER INJURY AND IN HEPATOCELLULAR CARCINOMA (HCC) AND IS MODULATED BY SOLUBLE FACTORS IN HCC CELLS (2010) (0)
- F-41 Sorafenib for hepatocellular carcinoma (HCC) in patients with established cirrhosis: impact of the type of recruiting unit and predictors of survival (2013) (0)
- Cholangiocarcinoma (CCA) express chemokine receptor CXCR7: Important role of CXCR7 in mediating CXCL12 induced CCA cells chemotaxis and survival (2014) (0)
- Regulation of the biology of cholangiocarcinoma (CCA) cells by the extracellular-signal regulated kinase 5 (ERK5) (2020) (0)
- Professor Paolo Gentilini, MD (1930–2015) (2015) (0)
- SAT-399-The profile on intracellular gangliosides correlates with the malignant phenotype of cholangiocarcinoma cells and modulates cells adhesion (2019) (0)
- P94 c-Rel AND p27Kip ARE DOWNSTREAM TARGETS OF ERK5 IN HEPATOCELLULAR CARCINOMA (HCC) IN VIVO AND IN VITRO (2014) (0)
- Faculty Opinions recommendation of Hepatic AdipoR2 signaling plays a protective role against progression of nonalcoholic steatohepatitis in mice. (2008) (0)
- Cellular and molecular mechanisms of hepatic fibrogenesis (2015) (0)
- F-32 Dietary supplementation with olive oil with or without n-3 PUFA differentially affects inflammation and progression of experimental nonalcoholic steatohepatitis (2012) (0)
- The mammalian target of rapamycin mediates the angiogenic and chemotactic effects of leptin in human hepatic stellate cells. (2010) (0)
- P291 INHIBITION OF INDOLEAMINE 2,3-DIOXYGENASE AMELIORATES INFLAMMATION AND FIBROSIS IN EXPERIMENTAL STEATOHEPATITIS (2014) (0)
- The CXCL12/CXCR7 system mediates migration and survival of cholangiocarcinoma (CCA) cells through interaction with CXCR4 and β-arrestin-2 (2016) (0)
- Regulation of the biology of cholangiocarcinoma (CCA) cells by Extracellular-signal-regulated kinase 5 (ERK5) (2020) (0)
- Acute presentation and male predominance in a series of adult patients with seronegative autoimmune hepatitis (2019) (0)
- MerTK-mediated cytokine secretion mediates a cross-talk between M2c macrophages and hepatic stellate cells (HSC) to induce fibrosis (2019) (0)
- Calcium-dependent activation of NF-kappa B by the adipokine resistin in hepatic stellate cells (2005) (0)
- Myeloid cell-specific deficiency of ERK5 regulates the response to liver regeneration after partial hepatectomy (PH) in mice (2020) (0)
- Correction to: CT volume of enhancement of disease (VED) can predict the early response to treatment and overall survival in patients with advanced HCC treated with sorafenib (2020) (0)
- Effects of supplementation with arachidonic acid on the lipid profileand platelet function in patients with cirrhosis (2000) (0)
- Faculty Opinions recommendation of A diet-induced animal model of non-alcoholic fatty liver disease and hepatocellular cancer. (2016) (0)
- Myeloid cell-specific deletion of ERK5 regulates the response to liver regeneration after partial hepatectomy (PH) in mice (2020) (0)
- Noninvasvie prediction of oesophageal varics by liver stiffness measurement and platelet values in patients with liver cirrhosis due to nonalcoholic fatty liver disease: A multicenter cross-sectional study (2018) (0)
- Dynamics of endothelial progenitor cells in patients with advanced hepatocellular carcinoma. (2021) (0)
- 1267 BERBERINE ADMINISTRATION AMELIORATES NECROINFLAMMATION IN EXPERIMENTAL STEATOHEPATITIS INTERFERING WITH THE INFLAMMASOME PATHWAY, BUT IS ASSOCIATED WITH EXTRAHEPATIC TOXICITY (2012) (0)
- Faculty Opinions recommendation of MicroRNA-379-5p inhibits tumor invasion and metastasis by targeting FAK/AKT signaling in hepatocellular carcinoma. (2016) (0)
- 1305 BERBERINE AMELIORATES HEPATIC INJURY IN MICE ACTING ON THE NALP3 INFLAMMASOME PATHWAY (2013) (0)
- Ganglioside patterns in the human cholangiocarcinoma stem cell subset A (2020) (0)
- Activation of the TSC/m-TOR pathway by PDGF or leptin is required for expression of VEGF by human hepatic stellate cells (2008) (0)
- THU-451-Characterization of cholangiocarcinoma primary, circulating and metastatic stem-like cells (2019) (0)
- 1131 THE MYOSTATIN SYSTEM IS EXPRESSED IN THE LIVER AND ITS ACTIVATION MEDIATES PROFIBROGENIC ACTIONS IN HEPATIC STELLATE CELLS (HSC) VIA c-Jun N-TERMINAL KINASE (JNK) (2013) (0)
- OC-04 Activation of the mitogen-activated protein kinase ERK5 regulates the development and growth of hepatocellular carcinoma (2013) (0)
- LIVER Dose dependent and divergent effects of superoxide anion on cell death , proliferation , and migration of activated human hepatic stellate cells (2005) (0)
- Hepatocyte-specific deletion of ERK5 worsens insulin resistance in a murine model of non-alcoholic fatty liver disease (NAFLD) (2020) (0)
- The CXCL12/CXCR7 System Mediates Migration and Survival of Cholangiocarcinoma (CCA) Cells through Interaction with CXCR4 and Barrestin-2 (2016) (0)
- Hypoxia – induced migration of human hepatic stellate cellsrequires an early and redox sensitive activation of c-Jun N-terminal kinase (2008) (0)
- c-Rel and p27Kip are downstream targets of ERK5 in hepatocellular carcinoma (HCC) in vivo and in vitro (2014) (0)
- F-30 The receptor CXCR7 contributes to proliferation and migration of hepatic stellate cells (2012) (0)
- Faculty Opinions recommendation of Modulation of biliary cancer chemo-resistance through microRNA-mediated rewiring of the expansion of CD133+ cells. (2020) (0)
- T-55 Functional role of the chemokine receptor CXCR7 on CXCL12-induced chemotaxis and cell survival in cholangiocarcinoma (CCA) cells (2013) (0)
- Reliability criteria for the diagnosis of fatty liver using controlled attenuation parameter by transient elastography – A multicentre study of 754 patients (2017) (0)
- Third in-flow as a cause of hepatic pseudo-lesions (2008) (0)
- F-47 The adipokine chemerin as a novel factor regulating the fibrogenic phenotype of human hepatic stellate cells (2011) (0)
- Post-transplant diabetes predicts solid extra-hepatic non-skin cancer in liver transplant recipients: a long-term follow-up study (2021) (0)
- From meetings (1988) (0)
- PRO-inflammatory and pro-fibrogenic actions of the HIV-envelope protein gp120 are mediated by inflammasome activation and MIR29B (2014) (0)
- Faculty Opinions recommendation of Prognostic value of desmoplastic stroma in intrahepatic cholangiocarcinoma. (2021) (0)
- Ganglioside composition correlates with the malignant phenotype of cholangiocarcinoma cells and modulates cell adhesion (2019) (0)
- Cholangiocarcinoma primary, circulating and metastatic stem-like cells (2019) (0)
- T-6 Oncostatin M stimulates chemotaxis of human hepatic profibrogenic cells (2011) (0)
- Stemness features during cholangiocarcinoma progression in vivo: characterization of primary and metastatic stem-like cells (2022) (0)
- Faculty Opinions recommendation of Metabolic Alterations in Spheroid-Cultured Hepatic Stellate Cells. (2021) (0)
- 1039 ACTIVATION OF THE MITOGEN-ACTIVATED PROTEIN KINASE ERK5 REGULATES THE DEVELOPMENT AND GROWTH OF HEPATOCELLULAR CARCINOMA (2013) (0)
- P1707QT interval in cirrhosis: dynamic changes during exercise suggest abnormal modulation of potassium currents (2017) (0)
- Interaction between 4-Hydroxy-2,3-alkenals and the Platelet-derived Growth Factor-β Receptor (2000) (0)
- Interferon-g-Mediated Activation of STAT 1 a Regulates Growth Factor – Induced Mitogenesis (2013) (0)
- Leptin receptors on human hepatic stellate cells mediate the expression of proangiogenic cytokines via activation of hypoxia inducile factor (2005) (0)
- 106 MYRISTOYLATED ALANINE RICH PROTEIN KINASE C SUBSTRATE (MARCKS), A FUNDAMENTAL CELL CYCLE REGULATOR OF THE MITOTIC PROCESS IN HUMAN HEPATIC STELLATE CELLS (HHSC) (2010) (0)
- Chemotaxis in Profibrogenic Human Hepatic Stellate Cells Requires Redox – Dependent Activation of c-Jun N-Terminal Kinase Isoforms 1 and 2 (2008) (0)
- The volume of enhancement of disease (VED) predicts the early response to treatment and overall survival in patients with advanced hepatocellular carcinoma treated with sorafenib (2020) (0)
- The inflammasome pathway as a target of berberine in experimental steatohepatitis and acetaminophen toxicity (2014) (0)
- Curcumin inhibits the fibrogenic progression of murine steatohepatitis (2007) (0)
- Inhibition of PDGF-dependent mitogenic signaling in human hepatic stellate cells exposed to pro-oxidant conditions (2001) (0)
- Silencing of Bcl-2 expression in human hepatic stellate cells turns off their survival attitude (2005) (0)
- AQP3 is regulated by PPARγ and JNK in hepatic stellate cells carrying PNPLA3 I148M (2017) (0)
- The I148M PNPLA3 impairs LXR signaling and cholesterol metabolism in human hepatic stellate cells (2018) (0)
- P85 CHOLANGIOCARCINOMA (CCA) EXPRESS CHEMOKINE RECEPTOR CXCR7: IMPORTANT ROLE OF CXCR7 IN MEDIATING CXCL12 INDUCED CCA CELLS CHEMOTAXIS AND SURVIVAL (2014) (0)
- Health-care burden of NAFLD in European hospital-based outpatient hepatology clinics: real-world prospective data from the CONSTANS study (2020) (0)
- Transient elastography (TE) is more effective for the identification of HCV patients with severe (≥F3) rather than significant (≥F2) liver fibrosis (2008) (0)
- Survival and phenotypic responses of fully activated human hepatic stellate cells to superoxide and TNF: critical role of generation rate and Bcl-2 levels (2005) (0)
- O4 BERBERINE ADMINISTRATION AMELIORATES EXPERIMENTAL STEATOHEPATITIS INTERFERING WITH THE INFLAMMASOME PATHWAY AND TLR-4 EXPRESSION (2012) (0)
- OC-4 Myostatin: a novel modulator of hepatic stellate cell biology (2012) (0)
- Faculty Opinions recommendation of Leptin-mediated neovascularization is a prerequisite for progression of nonalcoholic steatohepatitis in rats. (2006) (0)
- PS-033-Hepatocyte-specific deletion of ERK5 modulates liver regeneration in mice (2019) (0)
- Interferon-γ-mediated activation of stat1α regulates mitogenesis of hepatic stellate cells (1995) (0)
- REDOX- AND HIF-1α/VEGF - DEPENDENT MIGRATION OF HUMAN ACTIVATEDHEPATIC STELLATE CELLS EXPOSED TO ONCOSTATIN M (2011) (0)
- 324 Differential expression of two isoforms of the chemokine receptor CXCR3 determines the ultimate effect of IP-10 on survival of human hepatic stellate cells (HSC) (2004) (0)
- AccessReview Stemness features in liver cancer (2019) (0)
- The I148M PNPLA3 variant is a novel key player modulating the proinflammatory and profibrogenic phenotype of human hepatic stellate cells (2017) (0)
- 391 THE CHEMOKINE RECEPTOR CXCR7 CONTRIBUTES TO PROLIFERATION AND MIGRATION OF HEPATIC STELLATE CELLS (2012) (0)
- Expression of angiogenic cytokines by leptin requires the TSC/m-TOR pathway and generation of reactive oxygen species (ROS) in human hepatic stellate cells (2007) (0)
- PS-119-Time-varying mHAP III is the most accurate score in predicting survival in patients wit hepatocellular carcinoma undergoing trans-arterial chemoembolization (2019) (0)
- F-27 The inflammasome complex is a target of the HIV envelope protein gp120 in human hepatic stellate cells (HSC) and mononuclear cells (MNC) (2013) (0)
- 462 AMP-ACTIVATED PROTEIN KINASE (AMPK) REGULATES THE ACTIVATION PROCESS OF HEPATIC STELLATE CELLS (2008) (0)
- Common signalling and redox sensitive events regulate migration and chemotaxis of bone marrow – derived mesenchymal stem cells and hepatic stellate cells. (2009) (0)
- P620 THE AMPK-RELATED KINASE, Nuak2 IS MODULATED BY THE ACTIVATION PROCESS AND REGULATES MOTILITY OF HEPATIC STELLATE CELLS (HSC) (2014) (0)
- P0100 : QT adaptation during exercise in liver cirrhosis: Adjunctive signs of cirrhotic cardiomyopathy (2015) (0)
- AMP-activated protein kinase (AMPK) regulates the activation process of hepatic stellate cells (2008) (0)
- Biological therapies in patients with liver disease: are they really lifesavers? (2021) (0)
- Material deprivation affects the management and clinical outcome of hepatocellular carcinoma in a high-resource environment. (2021) (0)
- 1256 DIETARY SUPPLEMENTATION WITH OLIVE OIL WITH OR WITHOUT N-3 PUFA DIFFERENTIALLY AFFECTS INFLAMMATION AND PROGRESSION OF EXPERIMENTAL NONALCOHOLIC STEATOHEPATITIS (2012) (0)
- NGF and Trk-A as a novel autocrine loop in the early stages of hepatic stellate cell (HSC) activation (2002) (0)
- THE AMPK RELATED KINASE NUAK2 INTERACTS WITH TGF-BETA AND REGULATES THE ACTIVATION PROCESS OF HEPATIC STELLATE CELLS (HSC) (2015) (0)
- [113] NONALCOHOLIC FATTY LIVER DISEASE AND CORONARY, CAROTID AND FEMORAL ATHEROSCLEROSIS IN PATIENTS WITH ACUTE MYOCARDIAL INFARCTION. DOES AN ASSOCIATION OCCUR? (2009) (0)
- Pirfenidone improves NASH features induced by high fat/carbohydrate diet in mice (2014) (0)
- Thrombopoietin stimulates migration and invasion of HepG2 cells (2002) (0)
- [210] EVIDENCE FOR A PATHOGENETIC ROLE OF ASYMMETRIC DIMETHYLARGININE (ADMA) IN CIRRHOTIC PORTAL HYPERTENSION (2007) (0)
- Lack of CCL2 limits the development of HCC in a model of obesity-associated carcinogenesis (2019) (0)
- Free radical scavenging effects of sylibin-phosphati dylcholine (IdB1016) in patients with chronic liver disease. Preliminary results (1991) (0)
- 289 THE ACTIN CYTOSKELETON AS A NOVEL TARGET OF AMP-ACTIVATED PROTEIN KINASE (AMPK) IN HEPATIC STELLATE CELLS (2009) (0)
- Fatty Acids regulate the biology of cholangiocarcinoma cells (2020) (0)
- Early redox-sensitive activation of JNK isoforms switch on hypoxia-induced migration of human hepatic stellate cells (2008) (0)
- Abnormal glycosphingolipid patterns in human cholangiocarcinoma stem-like subsets (2021) (0)
- [319] AMP-ACTIVATED PROTEIN KINASE (AMPK) BLOCKS THE EFFECTS OF PDGF BY PI3K-INDEPENDENT SIGNALS AND IS DOWNREGULATED DURING IN VIVO ACTIVATION OF HEPATIC STELLATE CELLS (2007) (0)
- Regenerating hepatocytes are both source and target of fractalkine(FKN) during fulminant hepatitis (2000) (0)
- Delayed Identification by CT of Parenchymal Changes Induced by Ligation of a Portal Vein Branch in the Rat- Preliminary Report (2014) (0)
- 206 CYTOSKELETAL REARRANGEMENT BY THE MITOGEN-ACTIVATED PROTEIN KINASE ERK5 INTERFERES WITH THE MOTILE AND INVASIVE PHENOTYPE OF HEPATOCELLULAR CARCINOMA CELLS (2011) (0)
- Silencing of Bcl-2 by specific siRNA sensitizes human-activated hepatic stellate cells to TNF – induced apoptosis (2006) (0)
- Mechanisms of Fibrogenesis in NASH (2020) (0)
This paper list is powered by the following services:
What Schools Are Affiliated With Fabio Marra?
Fabio Marra is affiliated with the following schools:
